1 year return (CAGR)
-30.30%
Landos Biopharma Inc Exchange (NASDAQ, USD)
LABP
-
+0.13 (+0.58%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-42.50%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
71.68M
Price/Sales
-
Ent value
49.36M
Price/Book
3.10
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 22.93 |
| Daily high | 22.94 |
| Daily low | 22.75 |
| Daily Volume | 50K |
| 1y analyst estimate | 12.71 |
| Beta | 0.14 |
| EPS (TTM) | -3.99 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| LABP | S&P500 | |
| Current price drop from All-time high | -85.90% | -1.02% |
| Highest price drop | -98.68% | -56.47% |
| Date of highest drop | 30 Nov 2022 | 9 Mar 2009 |
| Avg drop from high | -75.84% | -10.68% |
| Avg time to new high | 139 days | 12 days |
| Max time to new high | 815 days | 1805 days |
News
No items found